Literature DB >> 19117980

Adenoviral E1A function through Myc.

Abhishek A Chakraborty1, William P Tansey.   

Abstract

The study of DNA tumor viruses has been invaluable in uncovering the cellular nodes and pathways that contribute to oncogenesis. Perhaps one of the best-studied oncoproteins encoded by a DNA tumor virus is adenovirus E1A, which modifies the function of key regulatory proteins such as retinoblastoma (Rb) and the chromatin remodeling protein p400. Although the interaction of E1A with Rb has long been known to target regulation of the E2F transcription factors, the downstream target of the E1A-p400 interaction has remained elusive. We have recently reported that a critical downstream link of the E1A-p400 nexus is the oncoprotein transcription factor c-Myc. Through its interaction with p400, E1A stabilizes Myc and promotes formation of Myc-p400 complexes on chromatin, leading to activation of Myc target genes. These findings point to an important role for p400 in Myc function and reveal that E1A drives oncogenesis by tapping into two important transcriptional networks: those of E2F and Myc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19117980     DOI: 10.1158/0008-5472.CAN-08-3026

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Contamination with E1A-positive wild-type adenovirus accounts for species-specific stimulation of islet cell proliferation by CCK: a cautionary note.

Authors:  Jeremy A Lavine; Philipp W Raess; Dawn B Davis; Mary E Rabaglia; Brent K Presley; Mark P Keller; Margery C Beinfeld; Alan S Kopin; Christopher B Newgard; Alan D Attie
Journal:  Mol Endocrinol       Date:  2010-01-15

2.  Homologous recombination-based adenovirus vector system for tumor cell-specific gene delivery.

Authors:  Qin Lu; Xun Ye; Fang Liu; Yi Zhao; Jie Qin; Min Liang; Chao Fang; Hong-Zhuan Chen
Journal:  Cancer Biol Ther       Date:  2013-06-12       Impact factor: 4.742

3.  Oncogene-induced sensitization to chemotherapy-induced death requires induction as well as deregulation of E2F1.

Authors:  G Vignir Helgason; Jim O'Prey; Kevin M Ryan
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

4.  MYC and Prostate Cancer.

Authors:  Cheryl M Koh; Charles J Bieberich; Chi V Dang; William G Nelson; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  Genes Cancer       Date:  2010-06

5.  Ad E1A 243R oncoprotein promotes association of proto-oncogene product MYC with the NuA4/Tip60 complex via the E1A N-terminal repression domain.

Authors:  Ling-Jun Zhao; Paul M Loewenstein; Maurice Green
Journal:  Virology       Date:  2016-09-22       Impact factor: 3.616

6.  E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization.

Authors:  María Llanos Valero; Francisco Jose Cimas; Laura Arias; Pedro Melgar-Rojas; Elena García; Juan Luis Callejas-Valera; Jesús García-Cano; Leticia Serrano-Oviedo; Miguel Ángel de la Cruz-Morcillo; Isabel Sánchez-Pérez; Ricardo Sánchez-Prieto
Journal:  Cell Cycle       Date:  2013-10-11       Impact factor: 4.534

7.  Metabolism goes viral.

Authors:  Shigeki J Miyake-Stoner; Clodagh C O'Shea
Journal:  Cell Metab       Date:  2014-04-01       Impact factor: 27.287

8.  MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells.

Authors:  Francisco J Cimas; Juan L Callejas-Valera; Raquel Pascual-Serra; Jesus García-Cano; Elena Garcia-Gil; Miguel A De la Cruz-Morcillo; Marta Ortega-Muelas; Leticia Serrano-Oviedo; J Silvio Gutkind; Ricardo Sánchez-Prieto
Journal:  Oncotarget       Date:  2015-12-29

9.  Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system.

Authors:  Zhen-Lin Nie; Yu-Qin Pan; Bang-Shun He; Ling Gu; Li-Ping Chen; Rui Li; Ye-Qiong Xu; Tian-Yi Gao; Guo-Qi Song; Andrew R Hoffman; Shu-Kui Wang; Ji-Fan Hu
Journal:  Mol Cancer       Date:  2012-11-21       Impact factor: 27.401

Review 10.  Going viral: a review of replication-selective oncolytic adenoviruses.

Authors:  Christopher Larson; Bryan Oronsky; Jan Scicinski; Gary R Fanger; Meaghan Stirn; Arnold Oronsky; Tony R Reid
Journal:  Oncotarget       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.